Effect of Peumus boldus on the labeling of red blood cells and plasma proteins with Technetium-99m

Applied Radiation and Isotopes

Volumn 51, Issue 2, 1999, Pages 145-149

  Wancke Reiniger, Ingrid ^a   Fonseca De Oliveira, Joelma ^a   Caldeira De Araújo, Adriano ^a   Bernardo Filho, Mario ^a,b  

^a Department of Physiological Sciences   (Brazil)

^b INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

Anti oxidant activity; Peumus boldus; Plasma proteins; Red blood cells; Technetium 99m

Indexed keywords

ANTIOXIDANTS; BLOOD; CELLS; DRUG PRODUCTS; PROTEINS; RADIOACTIVITY; SEPARATION; SOLUBILITY; TECHNETIUM;

PLASMA PROTEIN;

NUCLEAR MEDICINE;

ANTIOXIDANT; PERTECHNETIC ACID TC 99M; PLASMA PROTEIN; TRICHLOROACETIC ACID;

ANALYTIC METHOD; ARTICLE; ERYTHROCYTE MEMBRANE; ERYTHROCYTE VOLUME; HEART FUNCTION; HUMAN; HUMAN CELL; ISOTOPE LABELING; LUNG PERFUSION; NUCLEAR MEDICINE; PRIORITY JOURNAL; RADIOACTIVITY;

ANIMALS; BLOOD PROTEINS; ERYTHROCYTES; ISOTOPE LABELING; MEDICINE, TRADITIONAL; PLANT EXTRACTS; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR; SODIUM PERTECHNETATE TC 99M; TECHNETIUM;

EID: 0345085633     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8043(98)00200-0     Document Type: Article

References (30)

1. Bernardo-Filho M., Moura I.N.S., Boasquevisque E.M. 99m-Technetium-labeled red blood cells 'in vitro'. Arq. Biol. Tecnol. 26:1983;455-461.
2. Bernardo-Filho M., Caniné M.S., Lopes R.L., Boasquevisque E.M. Effect of temperature on the 'in vitro' labeling of red blood cells with Technetium-99m. Arq. Biol. Tecnol. 29:1986;407-412.
3. Bernardo-Filho M., Nogueira J.F., Sturm J.A., Boasquevisque E.M. Plasma proteins labeling with 99m-Technetium. Arq. Biol. Tecnol. 33:1990;811-817.
4. Bernardo-Filho M., Silva J.R.M., Reis R.J.N., Boasquevisque E.M., Hassón-Voloch A. Conditions for labeling of Schistosoma mansoni Cercaria with Technetium-99m. J. Nucl. Biol. Med. 36:1992;56-59.
5. Bernardo-Filho M., Pires E.T., Boasquevisque E.M., Hassón-Voloch A. Studies on the incorporation of 99m-Technetium to the platyhelminth Dugesia tigrina. Rev. Parasitol. XIIV:1993;7-11.
6. Bernardo-Filho M., Gutfilen G., Maciel O.S. Effect of different anticoagulants on the labeling of red blood cells and plasma proteins with Tc-99m. Nucl. Med. Comm. 15:1994;730-734.
7. Callahan R.J., Rabito C.A. Radiolabeling of erythrocytes with Technetium-99m: role of band-3 protein in the transport of pertechnetate across the cell membrane. J. Nucl. Med. 31:1990;2004-2008.
8. 99mTc ion to hemoglobin J. Nucl. Med. 15:1974;703-706.
9. Early, P.J., Sodee, D.B., 1995. Principles and Practice of Nuclear Medicine. Mosby Year Book, Toronto, 877 pp.
10. Genest K., Hughes D.W. Natural products in Canadian pharmaceuticals. II. Peumus boldus. Can. J. Pharm. Sci. 3:1968;84-92.
11. 99mTc Rev. Esp. Med. Nucl. 11:1992;195-199.
12. 99mTc -Labeled leukocytes obtained with a suitable technique: the biodistribution study in rabbits Acta Med. Biol. 41:1993;193-196.
13. Harbert, J.C., Eckelman, W.C., Neumann, R.D., 1996. Nuclear Medicine Diagnosis and Therapy. Thieme Medical Publishers, New York, 1256 pp.
14. Hesslewood S., Leung E. Drug interactions with radiopharmaceuticals. Eur. J. Nucl. Med. 21:1994;348-356.
15. Hladik, W.B. III, Saha, G.B., Study, K.T., 1987. Essentials of Nuclear Medicine Sciences. William and Wilkins, Sydney.
16. Ody, P., 1993. The Herb Society: Las Plantas Medicinales. Javier Vergara Editor S.A., Buenos Aires, 187 pp.
17. Oliveira J.F., Braga A.C.S., Ávila A.S., Gutfilen B., Bernardo-Filho M. Effect of Thuya occidentallis on the labeling of red blood cells and plasma proteins with Technetium-99m. Yale J. Biol. Med. 69:1997;489-494.
18. Perkins A.C., Frier M. Nuclear medicine techniques in the evaluation of pharmaceutical formulations. Pharm. World Sci. 18:1996;97-104.
19. Plotkowski M.C., Bernardo-Filho M., Meirelles M.N., Tournier J.M., Puchelle E. Pseudomonas aeruginosa binds to soluble cellular fibronectin. Curr. Microbiol. 26:1993;91-95.
20. Porter W.C., Dees S.M., Freitas J.E., Dworkin H.D. Acid-citrate-dextrose compared with heparin in the preparation in vivo/in vitro Technetium-99m red blood cells. J. Nucl. Med. 24:1983;383-387.
21. Rehani M., Sharma S.K. Site of Tc-99m binding to the red blood cell: concise communication. J. Nucl. Med. 21:1980;676-678.
22. Reutter, L., 1923. Traitè de Matière Médicale et de Chimie Végétale. Librairie J-B. Baillière et Fils, Paris, 900 pp.
23. Saha, G.B., 1992. Fundamentals of Nuclear Pharmacy. Springer-Verlag, New York, 331 pp.
24. Sallé, J.L., 1996. O Totum Em Fitoterapia. Robe Editorial, São Paulo, 237 pp.
25. Speisky H., Cassels B.K., Lissi E.A., Videla L.A. Antioxidant properties of the alkaloid boldine in systems undergoing lipid peroxidation and enzyme inactivation. Biochem. Pharmacol. 41:1991;1575-1581.
26. Srivastava S. State of the art (and science) of blood cell labeling. Brookhaven Lecture Series. 232:1987;1-14.
27. Srivastava S.C., Straub R.F. Evaluation of heparin and anticoagulant citrate dextrose in the preparation of Technetium-99m-red blood cell with Ultra Tag Rbc kit. J. Nucl. Med. 33:1992;307-308.
28. Tavares D.C., Takahashi C.S. Evaluation of the genotoxic potential of the alkaloid boldine in mammalian cell systems in vitro and in vivo. Mut. Res. 321:1994;139-145.
29. Teske, M., Trentini, A.M.M., 1995. Compêndio De Fitoterapia, 2nd ed. Herbarium Laboratório Botânico, Paraná, 317 pp.
30. Vidal M.V., Gutfilen B., Fonseca L.M.B., Bernardo-Filho M. Effect of the tobacco on the labeling of red blood cells and plasma proteins with Technetium-99m. J. Exp. Clin. Cancer Res. 17:1998;1-6.